Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Effective PCOS treatments require targeting specific signaling pathways.

The formulated gel is a promising treatment for alopecia areata.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Interleukin-15 can help hair growth and protect hair follicles.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Platycladus orientalis leaf extract helps hair grow by activating certain proteins.

Oxytocin receptors are found in skin cells near touch and pain neurons.

Oral tofacitinib successfully treated total body hair loss in one patient.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.